HEADER LYASE 26-JUN-00 1F74 TITLE CRYSTAL STRUCTURE ANALYSIS OF N-ACETYLNEURAMINATE LYASE FROM TITLE 2 HAEMOPHILUS INFLUENZAE: CRYSTAL FORM II COMPLEXED WITH 4-DEOXY-SIALIC TITLE 3 ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-ACETYL-NEURAMINATE LYASE; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: NAL; COMPND 5 EC: 4.1.3.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HAEMOPHILUS INFLUENZAE; SOURCE 3 ORGANISM_TAXID: 727; SOURCE 4 ATCC: 49247; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PKKTAC KEYWDS BETA BARREL, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR J.A.R.G.BARBOSA,B.J.SMITH,R.DEGORI,M.C.LAWRENCE REVDAT 5 13-JUL-11 1F74 1 VERSN REVDAT 4 24-FEB-09 1F74 1 VERSN REVDAT 3 11-JUL-06 1F74 1 AUTHOR JRNL REVDAT 2 01-APR-03 1F74 1 JRNL REVDAT 1 22-NOV-00 1F74 0 JRNL AUTH J.A.R.G.BARBOSA,B.J.SMITH,R.DEGORI,H.C.OOI,S.M.MARCUCCIO, JRNL AUTH 2 E.M.CAMPI,W.R.JACKSON,R.BROSSMER,M.SOMMER,M.C.LAWRENCE JRNL TITL ACTIVE SITE MODULATION IN THE N-ACETYLNEURAMINATE LYASE JRNL TITL 2 SUB-FAMILY AS REVEALED BY THE STRUCTURE OF THE JRNL TITL 3 INHIBITOR-COMPLEXED HAEMOPHILUS INFLUENZAE ENZYME. JRNL REF J.MOL.BIOL. V. 303 405 2000 JRNL REFN ISSN 0022-2836 JRNL PMID 11031117 JRNL DOI 10.1006/JMBI.2000.4138 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 78772 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3942 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4580 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 845 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1F74 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JUL-00. REMARK 100 THE RCSB ID CODE IS RCSB011325. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUN-97 REMARK 200 TEMPERATURE (KELVIN) : 113 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : MACSCIENCE REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 78893 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 37.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 53.5 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.09000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, SODIUM ACETATE, AMMONIUM REMARK 280 ACETATE, PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 32.60650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 59.00450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.60650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 59.00450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A TETRAMER CONSTRUCTED FROM REMARK 300 CHAINS A AND C GENERATED BY THE TWO-FOLD. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 13440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -64.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CE2 TYR C 136 NZ LYS C 164 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 121 CA - CB - CG ANGL. DEV. = 11.6 DEGREES REMARK 500 GLU A 270 CA - C - O ANGL. DEV. = -16.4 DEGREES REMARK 500 PRO A 271 CA - N - CD ANGL. DEV. = -10.8 DEGREES REMARK 500 PRO A 271 N - CA - CB ANGL. DEV. = 10.3 DEGREES REMARK 500 PRO A 271 N - CD - CG ANGL. DEV. = 8.7 DEGREES REMARK 500 ARG C 2 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 CYS C 102 CA - CB - SG ANGL. DEV. = 11.8 DEGREES REMARK 500 TYR C 110 N - CA - CB ANGL. DEV. = 11.0 DEGREES REMARK 500 TYR C 155 N - CA - CB ANGL. DEV. = 17.1 DEGREES REMARK 500 ARG C 269 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 GLU C 270 CA - C - O ANGL. DEV. = -16.4 DEGREES REMARK 500 PRO C 271 CA - N - CD ANGL. DEV. = -9.2 DEGREES REMARK 500 PRO C 271 N - CA - CB ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 71 -122.76 53.94 REMARK 500 PHE A 109 -162.97 -124.47 REMARK 500 TYR A 110 -66.73 71.93 REMARK 500 LYS C 71 -124.31 51.12 REMARK 500 PHE C 109 -165.04 -123.73 REMARK 500 TYR C 110 -52.41 64.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 270 PRO A 271 55.18 REMARK 500 GLU C 270 PRO C 271 50.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU A 270 20.27 REMARK 500 TYR C 155 -19.52 REMARK 500 GLU C 270 20.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1039 DISTANCE = 5.01 ANGSTROMS REMARK 525 HOH A1150 DISTANCE = 5.02 ANGSTROMS REMARK 525 HOH A1151 DISTANCE = 5.77 ANGSTROMS REMARK 525 HOH A1167 DISTANCE = 6.05 ANGSTROMS REMARK 525 HOH A1216 DISTANCE = 6.34 ANGSTROMS REMARK 525 HOH A1248 DISTANCE = 5.04 ANGSTROMS REMARK 525 HOH A1267 DISTANCE = 5.09 ANGSTROMS REMARK 525 HOH A1284 DISTANCE = 5.16 ANGSTROMS REMARK 525 HOH A1325 DISTANCE = 6.97 ANGSTROMS REMARK 525 HOH A1338 DISTANCE = 5.78 ANGSTROMS REMARK 525 HOH A1356 DISTANCE = 5.42 ANGSTROMS REMARK 525 HOH A1369 DISTANCE = 6.07 ANGSTROMS REMARK 525 HOH A1377 DISTANCE = 5.84 ANGSTROMS REMARK 525 HOH A1380 DISTANCE = 5.71 ANGSTROMS REMARK 525 HOH A1393 DISTANCE = 5.79 ANGSTROMS REMARK 525 HOH C1216 DISTANCE = 5.19 ANGSTROMS REMARK 525 HOH C1306 DISTANCE = 5.04 ANGSTROMS REMARK 525 HOH C1342 DISTANCE = 5.68 ANGSTROMS REMARK 525 HOH C1390 DISTANCE = 5.04 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL C 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAY A 950 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAY C 951 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 931 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 932 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 933 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 934 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NAL RELATED DB: PDB REMARK 900 N-ACETYLNEURAMINATE LYASE FROM ESCHERICHIA COLI. IZARD, T., REMARK 900 LAWRENCE, M.C., MALBY, R.L., LILLEY, G.G., COLMAN, P.M. THE REMARK 900 THREE-DIMENSIONAL STRUTURE OF N-ACETYLNEURAMINATE LYASE REMARK 900 FROM ESCHERICHIA COLI. STRUCTURE (1994) 2, 361. REMARK 900 RELATED ID: 1FDY RELATED DB: PDB REMARK 900 STRUCTURE AND MECHANISM OF A SUB-FAMILY OF ENZYMES RELATED REMARK 900 TO N-ACETYLNEURAMINATE LYASE. LAWRENCE, M.C., BARBOSA, REMARK 900 J.A.R.G., SMITH, B.J., HALL, N.E., PILLING, P.A., OOI, REMARK 900 H.C., MARCUCCIO, S.M. J. MOL. BIOL. (1997) 266, 381-399 REMARK 900 RELATED ID: 1FDZ RELATED DB: PDB REMARK 900 STRUCTURE AND MECHANISM OF A SUB-FAMILY OF ENZYMES RELATED REMARK 900 TO N-ACETYLNEURAMINATE LYASE. LAWRENCE, M.C., BARBOSA, REMARK 900 J.A.R.G., SMITH, B.J., HALL, N.E., PILLING, P.A., OOI, REMARK 900 H.C., MARCUCCIO, S.M. J. MOL. BIOL. (1997) 266, 381-399 REMARK 900 RELATED ID: 1F5Z RELATED DB: PDB REMARK 900 ACTIVE SITE MODULATION IN THE N-ACETYLNEURAMINATE LYASE SUB REMARK 900 -FAMILY AS REVEALED BY THE STRUCTURE OF THE INHIBITOR- REMARK 900 COMPLEXED HAEMOPHILUS INFLUENZAE ENZYME REMARK 900 RELATED ID: 1F6P RELATED DB: PDB REMARK 900 ACTIVE SITE MODULATION IN THE N-ACETYLNEURAMINATE LYASE SUB REMARK 900 -FAMILY AS REVEALED BY THE STRUCTURE OF THE INHIBITOR- REMARK 900 COMPLEXED HAEMOPHILUS INFLUENZAE ENZYME REMARK 900 RELATED ID: 1F6K RELATED DB: PDB REMARK 900 ACTIVE SITE MODULATION IN THE N-ACETYLNEURAMINATE LYASE SUB REMARK 900 -FAMILY AS REVEALED BY THE STRUCTURE OF THE INHIBITOR- REMARK 900 COMPLEXED HAEMOPHILUS INFLUENZAE ENZYME REMARK 900 RELATED ID: 1F73 RELATED DB: PDB REMARK 900 RELATED ID: 1F7B RELATED DB: PDB DBREF 1F74 A 1 293 UNP P44539 NANA_HAEIN 1 293 DBREF 1F74 C 1 293 UNP P44539 NANA_HAEIN 1 293 SEQADV 1F74 SER A 131 UNP P44539 ASN 131 SEE REMARK 999 SEQADV 1F74 LYS A 229 UNP P44539 ALA 229 SEE REMARK 999 SEQADV 1F74 ALA A 278 UNP P44539 GLU 278 SEE REMARK 999 SEQADV 1F74 VAL A 281 UNP P44539 LEU 281 SEE REMARK 999 SEQADV 1F74 SER C 131 UNP P44539 ASN 131 SEE REMARK 999 SEQADV 1F74 LYS C 229 UNP P44539 ALA 229 SEE REMARK 999 SEQADV 1F74 ALA C 278 UNP P44539 GLU 278 SEE REMARK 999 SEQADV 1F74 VAL C 281 UNP P44539 LEU 281 SEE REMARK 999 SEQRES 1 A 293 MET ARG ASP LEU LYS GLY ILE PHE SER ALA LEU LEU VAL SEQRES 2 A 293 SER PHE ASN GLU ASP GLY THR ILE ASN GLU LYS GLY LEU SEQRES 3 A 293 ARG GLN ILE ILE ARG HIS ASN ILE ASP LYS MET LYS VAL SEQRES 4 A 293 ASP GLY LEU TYR VAL GLY GLY SER THR GLY GLU ASN PHE SEQRES 5 A 293 MET LEU SER THR GLU GLU LYS LYS GLU ILE PHE ARG ILE SEQRES 6 A 293 ALA LYS ASP GLU ALA LYS ASP GLN ILE ALA LEU ILE ALA SEQRES 7 A 293 GLN VAL GLY SER VAL ASN LEU LYS GLU ALA VAL GLU LEU SEQRES 8 A 293 GLY LYS TYR ALA THR GLU LEU GLY TYR ASP CYS LEU SER SEQRES 9 A 293 ALA VAL THR PRO PHE TYR TYR LYS PHE SER PHE PRO GLU SEQRES 10 A 293 ILE LYS HIS TYR TYR ASP THR ILE ILE ALA GLU THR GLY SEQRES 11 A 293 SER ASN MET ILE VAL TYR SER ILE PRO PHE LEU THR GLY SEQRES 12 A 293 VAL ASN MET GLY ILE GLU GLN PHE GLY GLU LEU TYR LYS SEQRES 13 A 293 ASN PRO LYS VAL LEU GLY VAL LYS PHE THR ALA GLY ASP SEQRES 14 A 293 PHE TYR LEU LEU GLU ARG LEU LYS LYS ALA TYR PRO ASN SEQRES 15 A 293 HIS LEU ILE TRP ALA GLY PHE ASP GLU MET MET LEU PRO SEQRES 16 A 293 ALA ALA SER LEU GLY VAL ASP GLY ALA ILE GLY SER THR SEQRES 17 A 293 PHE ASN VAL ASN GLY VAL ARG ALA ARG GLN ILE PHE GLU SEQRES 18 A 293 LEU THR LYS ALA GLY LYS LEU LYS GLU ALA LEU GLU ILE SEQRES 19 A 293 GLN HIS VAL THR ASN ASP LEU ILE GLU GLY ILE LEU ALA SEQRES 20 A 293 ASN GLY LEU TYR LEU THR ILE LYS GLU LEU LEU LYS LEU SEQRES 21 A 293 GLU GLY VAL ASP ALA GLY TYR CYS ARG GLU PRO MET THR SEQRES 22 A 293 SER LYS ALA THR ALA GLU GLN VAL ALA LYS ALA LYS ASP SEQRES 23 A 293 LEU LYS ALA LYS PHE LEU SER SEQRES 1 C 293 MET ARG ASP LEU LYS GLY ILE PHE SER ALA LEU LEU VAL SEQRES 2 C 293 SER PHE ASN GLU ASP GLY THR ILE ASN GLU LYS GLY LEU SEQRES 3 C 293 ARG GLN ILE ILE ARG HIS ASN ILE ASP LYS MET LYS VAL SEQRES 4 C 293 ASP GLY LEU TYR VAL GLY GLY SER THR GLY GLU ASN PHE SEQRES 5 C 293 MET LEU SER THR GLU GLU LYS LYS GLU ILE PHE ARG ILE SEQRES 6 C 293 ALA LYS ASP GLU ALA LYS ASP GLN ILE ALA LEU ILE ALA SEQRES 7 C 293 GLN VAL GLY SER VAL ASN LEU LYS GLU ALA VAL GLU LEU SEQRES 8 C 293 GLY LYS TYR ALA THR GLU LEU GLY TYR ASP CYS LEU SER SEQRES 9 C 293 ALA VAL THR PRO PHE TYR TYR LYS PHE SER PHE PRO GLU SEQRES 10 C 293 ILE LYS HIS TYR TYR ASP THR ILE ILE ALA GLU THR GLY SEQRES 11 C 293 SER ASN MET ILE VAL TYR SER ILE PRO PHE LEU THR GLY SEQRES 12 C 293 VAL ASN MET GLY ILE GLU GLN PHE GLY GLU LEU TYR LYS SEQRES 13 C 293 ASN PRO LYS VAL LEU GLY VAL LYS PHE THR ALA GLY ASP SEQRES 14 C 293 PHE TYR LEU LEU GLU ARG LEU LYS LYS ALA TYR PRO ASN SEQRES 15 C 293 HIS LEU ILE TRP ALA GLY PHE ASP GLU MET MET LEU PRO SEQRES 16 C 293 ALA ALA SER LEU GLY VAL ASP GLY ALA ILE GLY SER THR SEQRES 17 C 293 PHE ASN VAL ASN GLY VAL ARG ALA ARG GLN ILE PHE GLU SEQRES 18 C 293 LEU THR LYS ALA GLY LYS LEU LYS GLU ALA LEU GLU ILE SEQRES 19 C 293 GLN HIS VAL THR ASN ASP LEU ILE GLU GLY ILE LEU ALA SEQRES 20 C 293 ASN GLY LEU TYR LEU THR ILE LYS GLU LEU LEU LYS LEU SEQRES 21 C 293 GLU GLY VAL ASP ALA GLY TYR CYS ARG GLU PRO MET THR SEQRES 22 C 293 SER LYS ALA THR ALA GLU GLN VAL ALA LYS ALA LYS ASP SEQRES 23 C 293 LEU LYS ALA LYS PHE LEU SER HET CL C 999 1 HET NAY A 950 20 HET NAY C 951 20 HET GOL C 931 6 HET GOL C 932 6 HET GOL A 933 6 HET GOL A 934 6 HETNAM CL CHLORIDE ION HETNAM NAY 6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO-2-OXONONANOIC HETNAM 2 NAY ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 CL CL 1- FORMUL 4 NAY 2(C11 H19 N O8) FORMUL 6 GOL 4(C3 H8 O3) FORMUL 10 HOH *845(H2 O) HELIX 1 1 ASN A 22 LYS A 36 1 15 HELIX 2 2 GLY A 46 GLU A 50 5 5 HELIX 3 3 GLU A 50 LEU A 54 5 5 HELIX 4 4 SER A 55 LYS A 71 1 17 HELIX 5 5 ASN A 84 GLY A 99 1 16 HELIX 6 6 SER A 114 GLY A 130 1 17 HELIX 7 7 GLY A 143 LYS A 156 1 14 HELIX 8 8 ASP A 169 TYR A 180 1 12 HELIX 9 9 PHE A 189 GLU A 191 5 3 HELIX 10 10 MET A 192 LEU A 199 1 8 HELIX 11 11 THR A 208 GLY A 213 1 6 HELIX 12 12 ASN A 212 ALA A 225 1 14 HELIX 13 13 LYS A 227 GLY A 249 1 23 HELIX 14 14 GLY A 249 GLU A 261 1 13 HELIX 15 15 THR A 277 LEU A 292 1 16 HELIX 16 16 ASN C 22 LYS C 36 1 15 HELIX 17 17 GLY C 46 GLU C 50 5 5 HELIX 18 18 GLU C 50 LEU C 54 5 5 HELIX 19 19 SER C 55 LYS C 71 1 17 HELIX 20 20 ASN C 84 GLY C 99 1 16 HELIX 21 21 SER C 114 GLY C 130 1 17 HELIX 22 22 GLY C 143 TYR C 155 1 13 HELIX 23 23 ASP C 169 TYR C 180 1 12 HELIX 24 24 PHE C 189 GLU C 191 5 3 HELIX 25 25 MET C 192 LEU C 199 1 8 HELIX 26 26 THR C 208 GLY C 213 1 6 HELIX 27 27 ASN C 212 ALA C 225 1 14 HELIX 28 28 LYS C 227 GLY C 249 1 23 HELIX 29 29 GLY C 249 LEU C 260 1 12 HELIX 30 30 THR C 277 LEU C 292 1 16 SHEET 1 A 9 GLY A 6 ALA A 10 0 SHEET 2 A 9 GLY A 41 VAL A 44 1 O GLY A 41 N SER A 9 SHEET 3 A 9 ALA A 75 GLN A 79 1 O ALA A 75 N LEU A 42 SHEET 4 A 9 CYS A 102 SER A 104 1 O CYS A 102 N ALA A 78 SHEET 5 A 9 MET A 133 TYR A 136 1 N ILE A 134 O LEU A 103 SHEET 6 A 9 VAL A 160 PHE A 165 1 N LEU A 161 O MET A 133 SHEET 7 A 9 LEU A 184 ALA A 187 1 N LEU A 184 O LEU A 161 SHEET 8 A 9 GLY A 203 GLY A 206 1 O GLY A 203 N ALA A 187 SHEET 9 A 9 GLY A 6 ALA A 10 1 O GLY A 6 N ALA A 204 SHEET 1 B 9 GLY C 6 ALA C 10 0 SHEET 2 B 9 GLY C 41 VAL C 44 1 O GLY C 41 N SER C 9 SHEET 3 B 9 ALA C 75 GLN C 79 1 O ALA C 75 N LEU C 42 SHEET 4 B 9 CYS C 102 SER C 104 1 O CYS C 102 N ALA C 78 SHEET 5 B 9 MET C 133 TYR C 136 1 N ILE C 134 O LEU C 103 SHEET 6 B 9 VAL C 160 PHE C 165 1 N LEU C 161 O MET C 133 SHEET 7 B 9 LEU C 184 ALA C 187 1 N LEU C 184 O LEU C 161 SHEET 8 B 9 GLY C 203 GLY C 206 1 O GLY C 203 N ALA C 187 SHEET 9 B 9 GLY C 6 ALA C 10 1 O GLY C 6 N ALA C 204 SITE 1 AC1 4 TYR C 180 PRO C 181 ASN C 182 HIS C 183 SITE 1 AC2 18 ALA A 10 TYR A 43 SER A 47 THR A 48 SITE 2 AC2 18 TYR A 136 LYS A 164 GLY A 188 PHE A 189 SITE 3 AC2 18 ASP A 190 GLU A 191 ILE A 205 GLY A 206 SITE 4 AC2 18 SER A 207 LEU A 250 HOH A1312 HOH A1313 SITE 5 AC2 18 HOH A1344 HOH A1373 SITE 1 AC3 19 ALA C 10 TYR C 43 SER C 47 THR C 48 SITE 2 AC3 19 TYR C 136 LYS C 164 GLY C 188 PHE C 189 SITE 3 AC3 19 ASP C 190 GLU C 191 ILE C 205 GLY C 206 SITE 4 AC3 19 SER C 207 LEU C 250 HOH C1260 HOH C1290 SITE 5 AC3 19 HOH C1296 HOH C1315 HOH C1329 SITE 1 AC4 9 ASN C 132 PRO C 158 LYS C 159 LEU C 161 SITE 2 AC4 9 GLU C 230 GOL C 932 HOH C1141 HOH C1176 SITE 3 AC4 9 HOH C1262 SITE 1 AC5 11 PRO C 158 VAL C 160 LEU C 161 ASN C 182 SITE 2 AC5 11 VAL C 214 GLN C 218 GOL C 931 HOH C1153 SITE 3 AC5 11 HOH C1154 HOH C1343 HOH C1371 SITE 1 AC6 8 ARG A 2 LYS A 67 ASP A 72 ASP A 101 SITE 2 AC6 8 ALA A 289 SER A 293 HOH A 977 HOH A1240 SITE 1 AC7 6 GLY A 226 LYS A 227 LEU A 228 LYS A 229 SITE 2 AC7 6 GLU A 230 HOH A1232 CRYST1 65.213 118.009 80.968 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015330 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008470 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012350 0.00000 MASTER 381 0 7 30 18 0 21 6 0 0 0 46 END